These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3998937)

  • 21. Biliary pharmacokinetics of ticarcillin and clavulanic acid.
    Owen AW; Faragher EB
    J Antimicrob Chemother; 1986 May; 17 Suppl C():65-70. PubMed ID: 3722048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticarcillin--clavulanic acid (Timentin).
    Med Lett Drugs Ther; 1985 Aug; 27(694):69-70. PubMed ID: 3894901
    [No Abstract]   [Full Text] [Related]  

  • 24. Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis.
    Burstein AH; Wyble LE; Gal P; Diaz PR; Ransom JL; Carlos RQ; Forrest A
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2024-8. PubMed ID: 7811013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT; Stockmann C; Young DC; Cash J; McDowell BJ; Korgenski K; Sherwin CM; Spigarelli M; Chatfield BA; Ampofo K
    Clin Ther; 2011 Nov; 33(11):1844-50. PubMed ID: 22018680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.
    Syrogiannopoulos GA; Al-Sabbagh A; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1296-300. PubMed ID: 3314696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
    Koeppe P; Höffler D; Hulla FW
    Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ticarcillin vs carbenicillin: clinical pharmacokinetics.
    Libke RD; Clarke JT; Ralph ED; Luthy RP; Kirby WM
    Clin Pharmacol Ther; 1975 Apr; 17(4):441-6. PubMed ID: 1122685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timentin (ticarcillin and clavulanic acid) in combination with aminoglycosides in the treatment of febrile episodes in neutropenic children.
    Schaison G; Reinert P; Leverger G; Leauté JB
    J Antimicrob Chemother; 1986 May; 17 Suppl C():177-81. PubMed ID: 3722043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timentin--clinical and pharmacokinetic evaluation in otorhinolaryngology.
    Federspil P; Koch A; Schätzle W; Tiesler E
    J Antimicrob Chemother; 1986 May; 17 Suppl C():103-13. PubMed ID: 3722042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ticarcillin and clavulanic acid given in combination to adult horses by intravenous and intramuscular routes.
    Sweeney RW; Beech J; Simmons RD; Soma LR
    J Vet Pharmacol Ther; 1988 Mar; 11(1):103-8. PubMed ID: 3379659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.
    Woodnutt G; Kernutt I; Mizen L
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1826-30. PubMed ID: 3501702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
    de Meirleire F; Fauchere JL; Simon G
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation.
    Lindsay CA; Bawdon R; Quigley R
    Pharmacotherapy; 1996; 16(3):458-62. PubMed ID: 8726606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology and safety evaluation of Timentin.
    Jackson D; Cockburn A; Cooper DL; Langley PF; Tasker TC; White DJ
    Am J Med; 1985 Nov; 79(5B):44-55. PubMed ID: 4073095
    [No Abstract]   [Full Text] [Related]  

  • 40. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.